AFG Venture Group Dispatches

Corporate advisory and consultancy in Australia, South East Asia and India.

Archive for Health and Life Sciences

CEDA report – ‘Healthcare: Reform or ration’

CEDA – the Committee for Economic Development of Australia – is a national, independent, member-based organisation providing thought leadership and policy perspectives on the economic and social issues affecting Australia. CEDA recently released its policy perspective entitled ‘Healthcare: Reform or ration’ available here: The Executive Summary discusses increase in health expenditure linked to increased level of utilisation […]

2011 – Another Big Year for Australian Biotech

David Langsam Editor, Biotech Daily Australian biotechnology companies are on a dramatically upward trajectory, which – barring major global upheavals – shows no sign of abating. 2011 is going to be a very big year for biotech, primarily because most of the Biotech Daily Top 20 Index (BDI-20) companies have several major milestones during the […]

Service Delivery Innovation Key to Meeting Private Health Insurance Customer Demand

Rhod McKensey Chief Marketing and Business Development Officer, nib The rapid adoption of new technology is changing the way we interact with our customers at nib health funds limited (nib). As customers move further away from traditional service models, we are continuing to invest in innovative and more engaging technology-based service channels that allow us […]

International Trends In Healthcare – The Consumer View of Healthcare In 2040

Dr Liz Paslawsky (formerley Gale), Phd, M.H.A, H1, BSc Company CEO, Dr Liz Paslawsky & Associates Extracts from a conference paper given in Brussels at the International Design and Health Conference – October 2010. The conference paper was in two parts. The first was the patient’s view of health care in 2040. The second was […]

What Is The Future For The Big Pharma Model?

Phil Kearney Director of Licensing & External Research, Merck, Sharp & Dohme The 2010 Pharmaceutical R&D Factbook, compiled by CMR International, painted a gloomy picture of the global pharmaceuticals sector. Most notable was the finding that new drugs launched within the last five years accounted for less than 7 percent of industry sales in 2009, […]